Bernie Sanders’ showdown with pharma CEOs is coming to a head
STAT surveyed key lawmakers on whether they would support Sen. Bernie Sanders' proposal to subpoena the CEOs of Merck and J&J over high drug prices.
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.
Bernie’s subpoena showdown
We’re less than a week away from a scheduled vote on subpoenaing the CEOs of two drugmakers, J&J and Merck. They would be the first subpoenas issued by the Senate HELP committee in more than 40 years, if the vote happens and goes in Chair Bernie Sanders’ favor. Sanders (I-Vt.) is publicly continuing his pressure campaign with a press conference today. It’s clearly part of his strategy, as he got the CEO of Starbucks to testify last year without the subpoena vote actually occurring.
What's Your Reaction?
